Michael King

Dr. Michael King is a professor of practice in the Department of Chemical Engineering at the University of VIrginia. Mike had a significant 32-year industrial experience at Merck and Co, Inc. including responsibilities in both the research and manufacturing areas related to the commercialization of new pharmaceuticals and vaccines. He retired as senior VP and advisor to the chairman, president and CEO. He is currently engaged with the Bill and Melinda Gates Foundation in helping de-risk commercialization of a new vaccine technology and previously, was on the Board of Directors of Medivation (acq. by Pfizer).